Home Retrogenix

Retrogenix

acquired
-
Biotechnology R&D Developer
Basic
Enterprise Profile

Basic Information

Retrogenix accelerates medical research and drug development for its clients by providing unique services to identify specific cell surface and secreted protein interactions in client cells. Retrogenix has now signed research agreements with 19 of the top 20 global pharmaceutical companies, numerous drug development firms, and many leading academic and non-profit institutions worldwide.
Retrogenix Ltd
England,United Kingdom
15~50 people
January 01, 2008
info@retrogenix.com

Enterprise Profile

Industrial Sector
Drug Trial Biological Drug Production Biological Product Manufacturing
Technology
Cell Technology Protein Technology
Concept
Immune System Diseases
Application Scenarios
Biologics Targeted drugs